Sign in
TerminatedNo phase

Ultrasound Detection and Characterization of Subclinical Hypertrophy in Diabetes

Key facts

Who runs it
University of British Columbia
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
100 people enrolled
Started
Mar 2015
Ended
22 Apr 2025
Type of study
Observational
Treatments tested
  • Ultrasound
Record updated
7 May 2025
Why it stopped
The study run its course

Who can take part

Age
19 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • 19 years of age or older
  • Type 1 or Type 2 diabetes
  • Using insulin to manage diabetes for at least 2 years

Who cannot take part

  • Using insulin pumps, insulin secretagogues, Glucagon-Like Peptide-1 (GLP-1) agonists to manage diabetes
  • Use of immunosuppressant agents
  • Women who are pregnant

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a pilot study to enroll 100 people to assess the incidence of lipohypertrophy as detected with ultrasound and its impact on glycemic variability.

Treatments tested

  • Ultrasound

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Ultrasound Guided Detection and Characterization of Subclinical Lipohypertrophy in Type 1 and Type 2 Diabetes Mellitus
Publications
Record updated
7 May 2025